3D Printing, Microfluidics & Organ-on-Chips Coming Together


Share this Article

In the recently published ‘Combining additive manufacturing with microfluidics: an emerging method for developing novel organs-on-chips,’ Chinese researchers are exploring a complex but increasingly popular topic in 3D printing, combining the technology with devices like organs-on-chips (OOCs).

As additive manufacturing continues to spur on new developments in research and other areas such as education (in nearly every grade—all the way up to the highest graduate degrees) and engineering, greater innovation continues in OOCs, microfluidic platforms used to imitate the functionality of human organs.

While OOCs were initially much more rudimentary and lacking in necessary adjustability, today they are incredibly advanced as scientists move closer and closer to their goal of being able to transplant 3D printed organs into the human body with success. And while bioprinting has progressed immensely, the technique is still laden with challenges due to the delicate nature of tissue engineering.

Recently, new efforts have been made to bioprint with OOCs, including projects such as:

  • Large-scale microfluidics
  • Precise 3D cellular architectures
  • Flow control for stable microenvironment maintenance
  • Generation of tissue/organ-level structures
  • Tissue-to-tissue interfaces


Concept of integrating AM with microfluidic for OOCs.

Schematics of 3D-cell printing methods with different working principles: (a1) micro-extrusion, (a2) inkjet-based and (a3) laser-assisted printing. Micro-extrusion based printing [12]. (b1) Rendering of the assembled syringe pump extruder and a printer. (b2) Time-lapse sequence of 3D bioprinting of a university logo. (b3) Printed collagen heart and the cross-sectional view of the collagen heart. Inkjet-based printing [16]. (c1) Schematic representation of 3D checkerboard composed of two patterns. Patterns of a university logo (c2), concentric circles, partial circles pattern and ‘Smiley face’ (c3) obtained by printing Fluo-ink (green) and Acri-ink (blue) containing Tomato NIH 3T3 fibroblasts (red). (g and h: scale bar 200 μm). (c4) A bioprinting hydrogel-based microfuidic chip. Scale bar: 1 mm. Laser-assisted printing [17]. (d1) Schematic of laser direct-write. (d2) Fabricated microbeads and laden cells. Scale bar: 200 μm. (d3) Confocal microscopy images of MDA-MB-231 3D aggregate. Scale bar: 100 μm. Reproduced with permissions from the American Association for the Advancement of Science [12] and Elsevier [17].

Bioprinting is usually separated into scaffold-based and scaffold-free methods. Scaffold-based bioinks are meant to:

  • Interact with cells
  • Provide vehicles for cell loading
  • Build scaffolds for tissue formation

They are often either naturally gleaned from materials like gelatin or alginate, as well as synthetics like polyethylene glycol and Pluronic©.

“In cell-laden hydrogels, biologically active components including growth factors, other extracellular matrix (ECM)-associated proteins are usually encapsulated for enhancing cell adhesion, cell proliferation or differentiation,” state the researchers. “Solidification of printed hydrogels is realized through thermal, photo cross-linking, or ionic/chemical cross-linking processes. Recently, hydrogel bioinks have been doped with nanomaterials for improving robustness and cell differentiation.”

As bioprinting continues to advance, we have seen:

  • Liver-on-a-chip
  • Bioprinted-heart-on-a-chip
  • Vasculature-on-a-chip

Characterization continues in 3D bioprinted OOCs also, assessing both development and functionality using biochemical and biomechanical analyses. As the research team points out though, cell viability is an ‘essential parameter’ when it comes to OOC development. Biochemical studies are used to test OOCs with genetic and protein expression information also.

“In brief, from a view of printing resolution, the extrusion-based printing, which has been the most widely accepted is still not yet compatible for all design when the on-chip structures become more sophisticated and heterogeneous. SLA has a higher resolution, but the cell viability is inevitably affected during laser or UV light exposing,” conclude the researchers.

“In parallel, integration of embedded physical, biochemical and optical sensors with OOCs can record real-time cell behavior and environmental parameters. All these innovations will extend the applications of bioprinting integrated OOCs in fundamental research and clinical settings.”

Organ-on-a-chip technology continues to progress in labs around the world, from advanced engineering methods to prototypes to help cut costs and even the use of such methods to combat viral threats.

What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.

3D bioprinting integrated with microfluidic OOCs. Liver-on-a-chip [33]. (a1) Digital designs and corresponding devices (a2) Fluorescent images of the hUVECs cultured within channels (green showing F-actin and blue showing nuclei). Scale bar: 100 μm. Heart-on-a-chip [36]. (b1) Principle of on-chip functionalized microtissue by coculture of hiPSC-CMs and normal human cardiac fibroblasts. (b2) Microfluidic chip for cell-laden droplet generation (above) followed by transforming to microgels (below). Scale bar: 100 μm. (b3) Micrographs of cultured hiPSC-CM/NHCF-Vs at days 1, 8, and 14. Kidney-on-a-chip [39]. (c1) Schematic of 3D vascularized proximal tubule fabrication process. (c2) Fabricated on-chip vascularized proximal tubule. Scale bar: 10 mm. (c3) Integration of 3D vascularized proximal tubule tissue with a closed-loop perfusion for measuring renal reabsorption. Vasculature-on-a-chip [42••]. (d1) Adaptations of mathematical space-filling curves to entangled vessel topologies of axial vessel and helix (up) and interpenetrating Hilbert curves (down) within hydrogels. Scale bar: 3 mm. (d2) Hepatic hydrogel carriers created by seeding endothelial cells (HUVECs) in the vascular network after printing. (d3) Confocal microscopy images of hepatocyte aggregates (Hep) in fibrin gel entrapped by hydrogel anchors. Scale bar: 1 mm. Reproduced with permissions from Elsevier [33], the American Chemical Society [36], the National Academy of Sciences of the United States of America [39] and the American Association for the Advancement of Science [42••].

[Source / Images: ‘Combining additive manufacturing with microfluidics: an emerging method for developing novel organs-on-chips’]

Share this Article

Recent News

Interview: Rethinking 3D Printing for High-Volume Production with Exentis

3D Printing Financials: Prodways’ Q1 2024 Revenue Drop and Accounting Overhaul


3D Design

3D Printed Art

3D Printed Food

3D Printed Guns

You May Also Like

3D Printing Financials: Fathom Struggles in Financial Quicksand During Critical Transition

Facing a year of key transitions and financial pressures, Fathom (Nasdaq: FTHM) has filed its annual report for 2023 with the U.S. Securities and Exchange Commission (SEC). The document outlines...

Latest Earnings Overview for Australian 3D Printing Firms Titomic and AML3D

Australian 3D printing manufacturing firms Titomic (ASX: TTT) and AML3D (ASX: AL3) reported their financial results for the period from July to December 2023, marking the first half of their...

3D Printing Webinar and Event Roundup: April 7, 2024

Webinars and events in the 3D printing industry are picking back up this week! Sea-Air-Space is coming to Maryland, and SAE International is sponsoring a 3D Systems webinar about 3D...

3D Printing Financials: Unpacking Farsoon and BLT’s 2023 Performance

In the Chinese 3D printing industry, two companies, Farsoon (SHA: 688433) and Bright Laser Technologies, or BLT (SHA: 688333), have recently unveiled their full-year earnings for 2023. Farsoon reported increases...